264 related articles for article (PubMed ID: 33579862)
1. Huntington's Disease Pathogenesis: Two Sequential Components.
Hong EP; MacDonald ME; Wheeler VC; Jones L; Holmans P; Orth M; Monckton DG; Long JD; Kwak S; Gusella JF; Lee JM
J Huntingtons Dis; 2021; 10(1):35-51. PubMed ID: 33579862
[TBL] [Abstract][Full Text] [Related]
2. Promotion of somatic CAG repeat expansion by Fan1 knock-out in Huntington's disease knock-in mice is blocked by Mlh1 knock-out.
Loupe JM; Pinto RM; Kim KH; Gillis T; Mysore JS; Andrew MA; Kovalenko M; Murtha R; Seong I; Gusella JF; Kwak S; Howland D; Lee R; Lee JM; Wheeler VC; MacDonald ME
Hum Mol Genet; 2020 Nov; 29(18):3044-3053. PubMed ID: 32876667
[TBL] [Abstract][Full Text] [Related]
3. A modifier of Huntington's disease onset at the MLH1 locus.
Lee JM; Chao MJ; Harold D; Abu Elneel K; Gillis T; Holmans P; Jones L; Orth M; Myers RH; Kwak S; Wheeler VC; MacDonald ME; Gusella JF
Hum Mol Genet; 2017 Oct; 26(19):3859-3867. PubMed ID: 28934397
[TBL] [Abstract][Full Text] [Related]
4. Huntington's Disease: Relationship Between Phenotype and Genotype.
Sun YM; Zhang YB; Wu ZY
Mol Neurobiol; 2017 Jan; 54(1):342-348. PubMed ID: 26742514
[TBL] [Abstract][Full Text] [Related]
5. Genetic modifiers of Mendelian disease: Huntington's disease and the trinucleotide repeat disorders.
Holmans PA; Massey TH; Jones L
Hum Mol Genet; 2017 Oct; 26(R2):R83-R90. PubMed ID: 28977442
[TBL] [Abstract][Full Text] [Related]
6. CAG Repeat Not Polyglutamine Length Determines Timing of Huntington's Disease Onset.
;
Cell; 2019 Aug; 178(4):887-900.e14. PubMed ID: 31398342
[TBL] [Abstract][Full Text] [Related]
7. Modifiers of Somatic Repeat Instability in Mouse Models of Friedreich Ataxia and the Fragile X-Related Disorders: Implications for the Mechanism of Somatic Expansion in Huntington's Disease.
Zhao X; Kumari D; Miller CJ; Kim GY; Hayward B; Vitalo AG; Pinto RM; Usdin K
J Huntingtons Dis; 2021; 10(1):149-163. PubMed ID: 33579860
[TBL] [Abstract][Full Text] [Related]
8. Population-specific genetic modification of Huntington's disease in Venezuela.
Chao MJ; Kim KH; Shin JW; Lucente D; Wheeler VC; Li H; Roach JC; Hood L; Wexler NS; Jardim LB; Holmans P; Jones L; Orth M; Kwak S; MacDonald ME; Gusella JF; Lee JM
PLoS Genet; 2018 May; 14(5):e1007274. PubMed ID: 29750799
[TBL] [Abstract][Full Text] [Related]
9. Huntington's Disease and Diabetes: Chronological Sequence of its Association.
Montojo MT; Aganzo M; González N
J Huntingtons Dis; 2017; 6(3):179-188. PubMed ID: 28968242
[TBL] [Abstract][Full Text] [Related]
10. Genetic Modification of Huntington Disease Acts Early in the Prediagnosis Phase.
Long JD; Lee JM; Aylward EH; Gillis T; Mysore JS; Abu Elneel K; Chao MJ; Paulsen JS; MacDonald ME; Gusella JF
Am J Hum Genet; 2018 Sep; 103(3):349-357. PubMed ID: 30122542
[TBL] [Abstract][Full Text] [Related]
11. Genetic Contributors to Intergenerational CAG Repeat Instability in Huntington's Disease Knock-In Mice.
Neto JL; Lee JM; Afridi A; Gillis T; Guide JR; Dempsey S; Lager B; Alonso I; Wheeler VC; Pinto RM
Genetics; 2017 Feb; 205(2):503-516. PubMed ID: 27913616
[TBL] [Abstract][Full Text] [Related]
12. Expanding the Spectrum of Genes Involved in Huntington Disease Using a Combined Clinical and Genetic Approach.
Mariani LL; Tesson C; Charles P; Cazeneuve C; Hahn V; Youssov K; Freeman L; Grabli D; Roze E; Noël S; Peuvion JN; Bachoud-Levi AC; Brice A; Stevanin G; Durr A
JAMA Neurol; 2016 Sep; 73(9):1105-14. PubMed ID: 27400454
[TBL] [Abstract][Full Text] [Related]
13. DNA repair in the trinucleotide repeat disorders.
Jones L; Houlden H; Tabrizi SJ
Lancet Neurol; 2017 Jan; 16(1):88-96. PubMed ID: 27979358
[TBL] [Abstract][Full Text] [Related]
14. Huntington Disease: Genetics, Prevention, and Therapy Approaches.
Yapijakis C
Adv Exp Med Biol; 2017; 987():55-65. PubMed ID: 28971447
[TBL] [Abstract][Full Text] [Related]
15. The Complexity of Clinical Huntington's Disease: Developments in Molecular Genetics, Neuropathology and Neuroimaging Biomarkers.
Tippett LJ; Waldvogel HJ; Snell RG; Vonsattel JP; Young AB; Faull RLM
Adv Neurobiol; 2017; 15():129-161. PubMed ID: 28674980
[TBL] [Abstract][Full Text] [Related]
16. Clinical Features of Huntington's Disease.
Ghosh R; Tabrizi SJ
Adv Exp Med Biol; 2018; 1049():1-28. PubMed ID: 29427096
[TBL] [Abstract][Full Text] [Related]
17. Identification of Genetic Factors that Modify Clinical Onset of Huntington's Disease.
Genetic Modifiers of Huntington’s Disease (GeM-HD) Consortium
Cell; 2015 Jul; 162(3):516-26. PubMed ID: 26232222
[TBL] [Abstract][Full Text] [Related]
18. Drugging DNA Damage Repair Pathways for Trinucleotide Repeat Expansion Diseases.
Benn CL; Gibson KR; Reynolds DS
J Huntingtons Dis; 2021; 10(1):203-220. PubMed ID: 32925081
[TBL] [Abstract][Full Text] [Related]
19. Methods for Assessing DNA Repair and Repeat Expansion in Huntington's Disease.
Massey T; McAllister B; Jones L
Methods Mol Biol; 2018; 1780():483-495. PubMed ID: 29856032
[TBL] [Abstract][Full Text] [Related]
20. Genetic modifiers of Huntington's disease.
Gusella JF; MacDonald ME; Lee JM
Mov Disord; 2014 Sep; 29(11):1359-65. PubMed ID: 25154728
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
